EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers

Adam Kiljańczyk, Milena Matuszczak iD, Wojciech Marciniak iD, Róża Derkacz iD, Klaudia Stempa, Piotr Baszuk iD, Marta Bryśkiewicz, Krzysztof Lubiński, Cezary Cybulski, Tadeusz Dębniak iD, Jacek Gronwald iD, Tomasz Huzarski und 18 weitere

Nutrients · 30.04.2024 · 16 (9) · 1370

DOI: 10.3390/nu16091370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.04.2024. Verfasst von Adam Kiljańczyk und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Lead, BRCA1 Protein. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science and Higher Education, Minister of Science and Higher Education “Regional Initiative of Excellence” in years 2019–2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 mutations substantially elevate the risks of breast and ovarian cancer. Various modifiers, including environmental factors, can influence cancer risk. Lead, a known carcinogen, has been associated with various cancers, but its impact on BRCA1 carriers remains unexplored. A cohort of 989 BRCA1 mutation carriers underwent genetic testing at the Pomeranian Medical University, Poland. Blood lead levels were measured using inductively coupled plasma mass spectrometry. Each subject was assigned to a category based on their tertile of blood lead. Cox regression analysis was used to assess cancer risk associations. Elevated blood lead levels (>13.6 μg/L) were associated with an increased risk of ovarian cancer (univariable: HR = 3.33; 95% CI: 1.23–9.00; p = 0.02; multivariable: HR = 2.10; 95% CI: 0.73–6.01; p = 0.17). No significant correlation was found with breast cancer risk. High blood lead levels are associated with increased risk of ovarian cancer in BRCA1 carriers, suggesting priority for preventive salpingo-oophorectomy. Potential risk reduction strategies include detoxification. Validation in diverse populations and exploration of detoxification methods for lowering lead levels are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsLeadBRCA1 ProteinHumansFemaleAdultMiddle AgedRisk FactorsPolandHeterozygoteMutationBiomarkers, TumorGenetic Predisposition to DiseaseAgedProportional Hazards Models

Stichwörter der Autor:innen

BRCA1cancermicroelementsovarian cancer

Substanzen

LeadBRCA1 ProteinBRCA1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-252 Szczecin, Poland.
  • Read-Gene, Grzepnica, ul. Alabastrowa 8, 72-003 Dobra, Poland.
  • Department of Clinical Genetics and Pathology, University of Zielona Góra, ul. Zyty 28, 65-046 Zielona Góra, Poland.
  • Department of Surgery and Oncology, University of Zielona Góra, Zyty 28, 65-046 Zielona Góra, Poland.
  • OPEN, Kazimierza Wielkiego 24 Str., 61-863 Poznań, Poland.
  • Medical and Diagnostic Center, Niklinowa 9, 08-110 Siedlce, Poland.

ORCID-Profile: Milena Matuszczak, Wojciech Marciniak, Róża Derkacz, Piotr Baszuk, Tadeusz Dębniak, Jacek Gronwald, Anna Jakubowska, Marek Szwiec, Małgorzata Stawicka-Niełacna, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Rodney J Scott, Steven A Narod, Jan Lubiński

Förderung

  • Minister of Science and Higher Education
  • Minister of Science and Higher Education “Regional Initiative of Excellence” in years 2019–2022

Zitieren

APA

Kiljańczyk, A., Matuszczak, M., Marciniak, W., Derkacz, R., Stempa, K., Baszuk, P., Bryśkiewicz, M., Lubiński, K., Cybulski, C., Dębniak, T., Gronwald, J., Huzarski, T., Lener, M. R., Jakubowska, A., Szwiec, M., Stawicka-Niełacna, M., Godlewski, D., Prusaczyk, A., Jasiewicz, A., …, & Lubiński, J. (2024). Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers. Nutrients, 16(9), 1370. https://doi.org/10.3390/nu16091370

Vancouver

Kiljańczyk A, Matuszczak M, Marciniak W, Derkacz R, Stempa K, Baszuk P, et al. Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers. Nutrients. 2024;16(9):1370. doi:10.3390/nu16091370

BibTeX
@article{Kiljaczyk2024,
  author = {Kiljańczyk, Adam and Matuszczak, Milena and Marciniak, Wojciech and Derkacz, Róża and Stempa, Klaudia and Baszuk, Piotr and Bryśkiewicz, Marta and Lubiński, Krzysztof and Cybulski, Cezary and Dębniak, Tadeusz and Gronwald, Jacek and Huzarski, Tomasz and Lener, Marcin R and Jakubowska, Anna and Szwiec, Marek and Stawicka-Niełacna, Małgorzata and Godlewski, Dariusz and Prusaczyk, Artur and Jasiewicz, Andrzej and Kluz, Tomasz and Tomiczek-Szwiec, Joanna and Kilar-Kobierzycka, Ewa and Siołek, Monika and Wiśniowski, Rafał and Posmyk, Renata and Jarkiewicz-Tretyn, Joanna and Sun, Ping and Scott, Rodney J and Narod, Steven A and Lubiński, Jan},
  title = {Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1370},
  doi = {10.3390/nu16091370}
}
Kostenlos starten →